Filing Flows › Alpha Teknova (TKNO) › Q3 2026
Alpha Teknova (TKNO) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Alpha Teknova (TKNO) reported revenue of $12.7M for the third quarter 2026 (Q3 2026), +22% from a year earlier and +4% from the quarter before. Operating margin was -25.2%, net loss $3.5M (27.5% of revenue).
Alpha Teknova, Q3 2026: revenue $12.7M (+22% year over year), operating margin -25.2%, net loss $3.5M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.7M | +4% | +22% |
| Operating profit | −$3.2M | — | — |
| Net earnings | −$3.5M | — | — |
| Operating cash flow | −$1.3M | — | — |
What changed
Revenue was $12.7M in Q3 2026, up 22% year over year and up 4% from the previous quarter. Lab Essentials was the largest line at 71% of revenue. Clinical Solutions added $1.5M year over year (up 86%), 65% of the total change.
Gross margin was 38.0%, up 7.3 points from Q3 2025. Operating costs exceeded revenue by $3.2M, an operating margin of -25.2%. Operating expenses grew 11% against revenue growth of 22%. The fastest-growing cost line was Sales & marketing (+34%). The quarter ended with a net loss of $3.5M, wider than the previous quarter's $3.2M loss.
Operating cash flow was −$1.3M. Non-cash charges added back $1.6M of depreciation and amortization and $612K of share-based compensation. Capital expenditures of $120K exceeded it, leaving free cash flow of −$1.4M.
Questions
What was Alpha Teknova's revenue in the third quarter 2026?
Alpha Teknova (TKNO) reported revenue of $12.7M for the third quarter 2026 (Q3 2026), +22% from a year earlier and +4% from the quarter before.
Was Alpha Teknova profitable in the third quarter 2026?
Operating loss was $3.2M (-25.2% of revenue) and net loss $3.5M.
Source: Alpha Teknova 10-Q on SEC EDGAR.